Otsuka’s Voyxact was granted accelerated approval from the FDA in November 2025 based on nine-month data.

The drug finerenone significantly slows the decline in kidney function in patients with chronic kidney disease (CKD) who do ...

By Siddhi Mahatole and Sriparna Roy June 4 (Reuters) - Otsuka Pharmaceutical said on Thursday its drug in a late-stage study preserved kidney function over 12 months in patients with a type of ...

A series of major studies has shown that finerenone preserves kidney function, reduces cardiovascular risk, and improves ...

Learn what GFR means, how it measures kidney function, and why it is one of the most important tests for kidney health.

Eating too much salt every day can silently damage your kidneys. Learn how sodium affects kidney health and how to reduce ...

Finerenone also reduced albuminuria at month 12 by 42% and lowered the risk of kidney failure or an eGFR decline of 40% or ...

A new meta-analysis highlights that prevalent nature of chronic kidney disease globally. Here is how it is spreading at a ...

The kidneys serve as the body’s primary filtration system, removing waste products and maintaining proper fluid balance. When alcohol enters the bloodstream, these vital organs bear significant ...

Phase III ALIGN study results showed reduced rate of kidney function decline by ~34% with Vanrafia vs placebo, based on ...

A new Lancet report warns chronic kidney disease is rising rapidly worldwide and could become the fifth leading cause of ...